Gene drives force a gene to spread through a population much more rapidly and to a greater extent than is predicted by standard evolutionary processes, even if it
This meeting addressed concerns of UK
Focus of workshop
The workshop discussed:
- In regard to deficiencies noted in EU and UK regulation – what changes to risk assessment
areappropriate in order to e.g. make comparisonwith alternative methods of control; incorporate consideration of benefits.
- In regard to concerns about lack of international guidance and the problems this can cause, how might the UK provide leadership in this regard, e.g. through
disseminationof best practice in research, application and regulatory responses.
- In addition to the current discussion about mechanisms for safety and risk management, consideration of drivers for unsafe practice – such
as:economic competitiveness; lack of understanding; shortage of funds partway through; public demand for rapid application; fear of public resistance – and how to address these.
- Steps to developing sustained sciencepolicy engagement to support appropriate responses to new applications of genetic technologies on a casebycase basis. Specifically, the workshop will ask if there is a need for regulation beyond the scope of existing GM regulations and other relevant areas of legislation.
Workshop Briefing paper available here: CSER GeneDriveBriefingPaper
The workshop was co-organised with Cambridge University’s Synthetic Biology Strategic Research Initiative, and the Centre for Law, Medicine and the Life Sciences. It was supported in part by a grant from the Hauser-Raspe Foundation.